-
公开(公告)号:US20220281890A1
公开(公告)日:2022-09-08
申请号:US17689194
申请日:2022-03-08
申请人: Shionogi & Co., Ltd.
IPC分类号: C07D498/14 , A61P43/00 , A61P31/12 , A61P31/16 , A61K31/5383
摘要: The present invention provides a pharmaceutical composition containing the following compound having antiviral action: P is hydrogen or a group to form a prodrug; A1 is CR1AR1B, S or O; A2 is CR2AR2B, S or O; A3 is CR3AR3B, S or O; A4 is each independently CR4AR4B, S or O; the number of hetero atoms among atoms constituting the ring which consists of A1, A2, A3, A4, nitrogen atom adjacent to A1 and carbon atom adjacent to A4, is 1 or 2; R1A and R1B are each independently hydrogen, halogen, alkyl, or the like; R2A and R2B are each independently hydrogen, halogen, alkyl, or the like; R3A and R3B are each independently hydrogen, halogen, alkyl, or the like; R4A and R4B are each independently hydrogen, halogen, alkyl, or the like; R3A and R3B may be taken together with an adjacent carbon atom to form non-aromatic carbocycle or non-aromatic heterocycle; R1 is fluorine; m is any integer of 1 to 2; and n is any integer of 1 to 2.
-
公开(公告)号:US20210292321A1
公开(公告)日:2021-09-23
申请号:US17255566
申请日:2019-06-29
发明人: Akihiro ISHII , Akihiko SATO , Makoto KAWAI , Yoshiyuki TAODA
IPC分类号: C07D471/04 , C07D471/14 , C07D498/14 , A61P31/14
摘要: The present invention provides a compound having antiviral activity, especially having arenavirus proliferation inhibitory activity, and/or a medicament comprising the compound. More preferably, the present invention provides a compound having proliferation inhibitory activity on the Old World arenaviruses such as Luna virus, Lassa virus, and lymphocytic choriomeningitis virus and/or the New World arenaviruses such as Junin virus, and/or a medicament comprising the compound.
An arenavirus proliferation inhibitor comprising a compound represented by Formula (I) or a prodrug thereof or a pharmaceutically acceptable salt thereof: (wherein R1 is carboxy, or the like; A3 is CR2 or N; R2 is a hydrogen atom, halogen, hydroxy, or the like; R3 is a hydrogen atom, hydroxy, carboxy, cyano, formyl, alkyl optionally substituted with Substituent group F, or the like; either A1 or A2 is CR6R6, and the other is NR7, or A1 is CR8R9, and A2 is CR10R11; and R5, R6, R7, R8, R9, R10, and R11 are each independently a hydrogen atom, carboxy, cyano, alkyl optionally substituted with Substituent group F, or the like).-
3.
公开(公告)号:US20190169206A1
公开(公告)日:2019-06-06
申请号:US16323580
申请日:2017-08-09
申请人: Shionogi & Co., Ltd.
IPC分类号: C07D498/14 , A61P31/16
摘要: The present invention provides a pharmaceutical composition containing the following compound having antiviral action: wherein each of the symbols is defined in the specification.
-
公开(公告)号:US20240182463A1
公开(公告)日:2024-06-06
申请号:US18230392
申请日:2023-08-04
申请人: Shionogi & Co., Ltd.
发明人: Chika TAKAHASHI , Hidenori MIKAMIYAMA , Toshiyuki AKIYAMA , Kenji TOMITA , Yoshiyuki TAODA , Makoto KAWAI , Kosuke ANAN , Masayoshi MIYAGAWA , Naoyuki SUZUKI
IPC分类号: C07D471/04 , A61K31/4738 , C07D471/14 , C07F9/6561
CPC分类号: C07D471/04 , A61K31/4738 , C07D471/14 , C07F9/6561 , C07F9/65616
摘要: The present invention provides a compound having antiviral effects, particularly having growth inhibitory activity on influenza viruses, a preferred example of the compound being a substituted 3-hydroxy-4-pyridone derivative prodrug having cap-dependent endonuclease inhibitory activity.
-
公开(公告)号:US20200283455A1
公开(公告)日:2020-09-10
申请号:US16826623
申请日:2020-03-23
申请人: Shionogi & Co., Ltd.
IPC分类号: C07D498/14 , A61K31/53 , A61K31/5383 , A61K31/542 , A61K31/553 , A61K31/675 , C07F9/6561 , C07D471/14 , C07D471/20 , C07D491/22 , C07D513/14 , A61P31/16 , C07D519/00 , C07F7/18
摘要: The present invention provides the following compounds having anti-viral activity. A1 is CR1AR1B, S or O; A2 is CR2AR2B, S or O; A3 is CR3AR3B, S or O; A4 is CR4AR4B, S or O; the number of hetero atoms among atoms constituting the ring which consists of A1, A2, A3, A4, nitrogen atom adjacent to A1 and carbon atom adjacent to A1, is 1 or 2; R1A and R1B are each independently hydrogen, halogen, alkyl, or the like; R2A and R2B are each independently hydrogen, halogen, alkyl, or the like; R3A and R3B are each independently hydrogen, halogen, alkyl, or the like; R4A and R4B are each independently hydrogen, halogen, alkyl, or the like; R3A and R3B may be taken together to form non-aromatic carbocycle or non-aromatic heterocycle; X is CH2, S or O; R1 is each independently halogen, hydroxy, or the like; m is any integer of 0 to 2; and n is any integer of 1 to 2.
-
公开(公告)号:US20190112315A1
公开(公告)日:2019-04-18
申请号:US16221733
申请日:2018-12-17
申请人: Shionogi & Co., Ltd.
IPC分类号: C07D498/14 , C07F7/18 , A61K31/53 , C07D519/00 , A61K31/5383 , A61P31/16 , C07D513/14 , C07D491/22 , C07D471/20 , C07D471/14 , C07F9/6561 , A61K31/675 , A61K31/553 , A61K31/542
摘要: The present invention provides the following compounds having anti-viral activity. A1 is CR1AR1B, S or O; A2 is CR2AR2B, S or O; A3 is CR3AR3B, S or O; A4 is CR4AR4B, S or O; the number of hetero atoms among atoms constituting the ring which consists of A1, A2, A3, A4, nitrogen atom adjacent to A1 and carbon atom adjacent to A1, is 1 or 2; R1A and R1B are each independently hydrogen, halogen, alkyl, or the like; R2A and R2B are each independently hydrogen, halogen, alkyl, or the like; R3A and R3B are each independently hydrogen, halogen, alkyl, or the like; R4A and R4B are each independently hydrogen, halogen, alkyl, or the like; R3A and R3B may be taken together to form non-aromatic carbocycle or non-aromatic heterocycle; X is CH2, S or O; R1 is each independently halogen, hydroxy, or the like; m is any integer of 0 to 2; and n is any integer of 1 to 2.
-
公开(公告)号:US20240327424A1
公开(公告)日:2024-10-03
申请号:US18424022
申请日:2024-01-26
申请人: Shionogi & Co., Ltd.
IPC分类号: C07D498/14 , A61K31/53 , A61K31/5383 , A61K31/542 , A61K31/553 , A61K31/675 , A61P31/16 , C07D471/14 , C07D471/20 , C07D491/22 , C07D513/14 , C07D519/00 , C07F7/18 , C07F9/6561
CPC分类号: C07D498/14 , A61K31/53 , A61K31/5383 , A61K31/542 , A61K31/553 , A61K31/675 , A61P31/16 , C07D471/14 , C07D471/20 , C07D491/22 , C07D513/14 , C07D519/00 , C07F7/1804 , C07F9/6561 , C07C2601/08 , C07C2601/16
摘要: The present inventon provides the following compounds having anti-viral activity.
A1 is CR1AR1B, S or O;
A2 is CR2AR2B, S or O;
A3 is CR3AR3B, S or O;
A4 is CR4AR4B, S or O;
the number of hetero atoms among atoms constituting the ring which consists of A1, A2, A3, A4, nitrogen atom adjacent to A1 and carbon atom adjacent to A1, is 1 or 2;
R1A and R1B are each independently hydrogen, halogen, alkyl, or the like;
R2A and R2B are each independently hydrogen, halogen, alkyl, or the like;
R3A and R3B are each independently hydrogen, halogen, alkyl, or the like;
R4A and R4B are each independently hydrogen, halogen, alkyl, or the like;
R3A and R3B may be taken together to form non-aromatic carbocycle or non-aromatic heterocycle;
X is CH2, S or O;
R1 is each independently halogen, hydroxy, or the like;
m is any integer of 0 to 2; and
n is any integer of 1 to 2.-
公开(公告)号:US20190248785A1
公开(公告)日:2019-08-15
申请号:US16194504
申请日:2018-11-19
申请人: Shionogi & Co., Ltd.
发明人: Chika TAKAHASHI , Hidenori MIKAMIYAMA , Toshiyuki AKIYAMA , Kenji TOMITA , Yoshiyuki TAODA , Makoto KAWAI , Kosuke ANAN , Masayoshi MIYAGAWA , Naoyuki SUZUKI
IPC分类号: C07D471/04 , C07F9/6561 , A61K31/4738 , C07D471/14
CPC分类号: C07D471/04 , A61K31/4738 , C07D471/14 , C07F9/6561 , C07F9/65616
摘要: The present invention provides a compound having antiviral effects, particularly having growth inhibitory activity on influenza viruses, a preferred example of the compound being a substituted 3-hydroxy-4-pyridone derivative prodrug having cap-dependent endonuclease inhibitory activity.
-
公开(公告)号:US20230287004A1
公开(公告)日:2023-09-14
申请号:US18080247
申请日:2022-12-13
申请人: Shionogi & Co., Ltd.
IPC分类号: C07D498/14 , A61K31/53 , A61K31/5383 , A61K31/542 , A61K31/553 , A61K31/675 , C07F9/6561 , C07D471/14 , C07D471/20 , C07D491/22 , C07D513/14 , A61P31/16 , C07D519/00 , C07F7/18
CPC分类号: C07D498/14 , A61K31/53 , A61K31/5383 , A61K31/542 , A61K31/553 , A61K31/675 , C07F9/6561 , C07D471/14 , C07D471/20 , C07D491/22 , C07D513/14 , A61P31/16 , C07D519/00 , C07F7/1804 , C07C2601/08 , C07C2601/16
摘要: The present invention provides the following compounds having anti-viral activity.
A1 is CR1AR1B, S or O;
A2 is CR2AR2B, S or O;
A3 is CR3AR3B, S or O;
A4 is CR4AR4B, S or O;
the number of hetero atoms among atoms constituting the ring which consists of A1,
A2, A3, A4, nitrogen atom adjacent to A1 and carbon atom adjacent to A1, is 1 or 2;
R1A and R1B are each independently hydrogen, halogen, alkyl, or the like;
R2A and R2B are each independently hydrogen, halogen, alkyl, or the like;
R3A and R3B are each independently hydrogen, halogen, alkyl, or the like;
R4A and R4B are each independently hydrogen, halogen, alkyl, or the like;
R3A and R3B may be taken together to form non-aromatic carbocycle or non-aromatic heterocycle;
X is CH2, S or O;
R1 is each independently halogen, hydroxy, or the like;
m is any integer of 0 to 2; and
n is any integer of 1 to 2.-
公开(公告)号:US20230117695A1
公开(公告)日:2023-04-20
申请号:US17957103
申请日:2022-09-30
发明人: Akihiro ISHII , Akihiko SATO , Makoto KAWAI , Yoshiyuki TAODA
IPC分类号: C07D471/04 , A61P31/14 , C07D471/14 , C07D498/14
摘要: The present invention provides a compound having antiviral activity, especially having arenavirus proliferation inhibitory activity, and/or a medicament comprising the compound. More preferably, the present invention provides a compound having proliferation inhibitory activity on the Old World arenaviruses such as Luna virus, Lassa virus, and lymphocytic choriomeningitis virus and/or the New World arenaviruses such as Junin virus, and/or a medicament comprising the compound.
An arenavirus proliferation inhibitor comprising a compound represented by Formula (I) or a prodrug thereof or a pharmaceutically acceptable salt thereof. (wherein R1 is carboxy, or the like: A3 is CR2 or N; R2 is a hydrogen atom, halogen, hydroxy, or the like: R3 is a hydrogen atom, hydroxy, carboxy, cyano, formyl, alkyl optionally substituted with Substituent group F, or the like; either A1 or A2 is CR5R6, and the other is NR7, or A1 is CR8R9, and A2 is CR10OR11; and R5, R6, R7, R8, R9, R10, and R11 are each independently a hydrogen atom, carboxy, cyano, alkyl optionally substituted with Substituent group F, or the like).
-
-
-
-
-
-
-
-
-